vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and CPI Card Group Inc. (PMTS). Click either name above to swap in a different company.
CPI Card Group Inc. is the larger business by last-quarter revenue ($153.1M vs $85.1M, roughly 1.8× 4D Molecular Therapeutics, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 4.8%, a 18.0% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 22.3%). CPI Card Group Inc. produced more free cash flow last quarter ($35.2M vs $28.5M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 16.9%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
CPI Card Group Inc. is a leading provider of payment card production and associated solutions, including contactless and contact credit/debit cards, prepaid cards, and card personalization services. It primarily serves financial institutions, fintech firms, and retail brands across its core North American market.
FDMT vs PMTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $153.1M |
| Net Profit | $19.4M | $7.3M |
| Gross Margin | — | 31.5% |
| Operating Margin | 17.3% | 12.0% |
| Net Margin | 22.8% | 4.8% |
| Revenue YoY | 8508900.0% | 22.3% |
| Net Profit YoY | 139.1% | 8.5% |
| EPS (diluted) | $0.43 | $0.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $153.1M | ||
| Q3 25 | $90.0K | $138.0M | ||
| Q2 25 | $15.0K | $129.8M | ||
| Q1 25 | $14.0K | $122.8M | ||
| Q4 24 | $1.0K | $125.1M | ||
| Q3 24 | $3.0K | $124.8M | ||
| Q2 24 | $5.0K | $118.8M | ||
| Q1 24 | $28.0K | $111.9M |
| Q4 25 | $19.4M | $7.3M | ||
| Q3 25 | $-56.9M | $2.3M | ||
| Q2 25 | $-54.7M | $518.0K | ||
| Q1 25 | $-48.0M | $4.8M | ||
| Q4 24 | — | $6.8M | ||
| Q3 24 | $-43.8M | $1.3M | ||
| Q2 24 | $-35.0M | $6.0M | ||
| Q1 24 | $-32.4M | $5.5M |
| Q4 25 | — | 31.5% | ||
| Q3 25 | — | 29.7% | ||
| Q2 25 | — | 30.9% | ||
| Q1 25 | — | 33.2% | ||
| Q4 24 | — | 34.1% | ||
| Q3 24 | — | 35.8% | ||
| Q2 24 | — | 35.7% | ||
| Q1 24 | — | 37.1% |
| Q4 25 | 17.3% | 12.0% | ||
| Q3 25 | -67983.3% | 9.4% | ||
| Q2 25 | -396373.3% | 7.3% | ||
| Q1 25 | -383007.1% | 11.5% | ||
| Q4 24 | — | 12.7% | ||
| Q3 24 | -1704400.0% | 14.3% | ||
| Q2 24 | -849120.0% | 12.5% | ||
| Q1 24 | -136200.0% | 12.6% |
| Q4 25 | 22.8% | 4.8% | ||
| Q3 25 | -63195.6% | 1.7% | ||
| Q2 25 | -364386.7% | 0.4% | ||
| Q1 25 | -342657.1% | 3.9% | ||
| Q4 24 | — | 5.4% | ||
| Q3 24 | -1461433.3% | 1.0% | ||
| Q2 24 | -699060.0% | 5.1% | ||
| Q1 24 | -115717.9% | 4.9% |
| Q4 25 | $0.43 | $0.62 | ||
| Q3 25 | $-1.01 | $0.19 | ||
| Q2 25 | $-0.98 | $0.04 | ||
| Q1 25 | $-0.86 | $0.40 | ||
| Q4 24 | — | $0.56 | ||
| Q3 24 | $-0.79 | $0.11 | ||
| Q2 24 | $-0.63 | $0.51 | ||
| Q1 24 | $-0.66 | $0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $21.7M |
| Total DebtLower is stronger | — | $286.7M |
| Stockholders' EquityBook value | $505.7M | $-17.3M |
| Total Assets | $566.7M | $403.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $21.7M | ||
| Q3 25 | $305.1M | $16.0M | ||
| Q2 25 | $293.2M | $17.1M | ||
| Q1 25 | $321.4M | $31.5M | ||
| Q4 24 | $424.9M | $33.5M | ||
| Q3 24 | $501.9M | $14.7M | ||
| Q2 24 | $541.9M | $7.5M | ||
| Q1 24 | $525.9M | $17.1M |
| Q4 25 | — | $286.7M | ||
| Q3 25 | — | $308.4M | ||
| Q2 25 | — | $310.9M | ||
| Q1 25 | — | $280.7M | ||
| Q4 24 | — | $280.4M | ||
| Q3 24 | — | $280.2M | ||
| Q2 24 | — | $269.7M | ||
| Q1 24 | — | $265.3M |
| Q4 25 | $505.7M | $-17.3M | ||
| Q3 25 | $369.0M | $-25.7M | ||
| Q2 25 | $420.9M | $-29.0M | ||
| Q1 25 | $469.7M | $-29.7M | ||
| Q4 24 | $510.6M | $-35.6M | ||
| Q3 24 | $552.9M | $-42.8M | ||
| Q2 24 | $588.3M | $-44.6M | ||
| Q1 24 | $600.6M | $-48.5M |
| Q4 25 | $566.7M | $403.2M | ||
| Q3 25 | $424.0M | $407.1M | ||
| Q2 25 | $473.6M | $399.8M | ||
| Q1 25 | $515.7M | $351.9M | ||
| Q4 24 | $560.4M | $349.7M | ||
| Q3 24 | $604.0M | $342.3M | ||
| Q2 24 | $620.1M | $321.4M | ||
| Q1 24 | $629.9M | $319.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $39.6M |
| Free Cash FlowOCF − Capex | $28.5M | $35.2M |
| FCF MarginFCF / Revenue | 33.5% | 23.0% |
| Capex IntensityCapex / Revenue | 0.1% | 2.9% |
| Cash ConversionOCF / Net Profit | 1.47× | 5.39× |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $41.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $39.6M | ||
| Q3 25 | $-46.5M | $10.0M | ||
| Q2 25 | $-43.4M | $4.3M | ||
| Q1 25 | $-47.8M | $5.6M | ||
| Q4 24 | $-134.6M | $26.7M | ||
| Q3 24 | $-29.4M | $12.5M | ||
| Q2 24 | $-30.2M | $-4.8M | ||
| Q1 24 | $-29.1M | $8.9M |
| Q4 25 | $28.5M | $35.2M | ||
| Q3 25 | $-46.6M | $5.3M | ||
| Q2 25 | $-43.4M | $533.0K | ||
| Q1 25 | $-48.4M | $292.0K | ||
| Q4 24 | $-138.4M | $21.6M | ||
| Q3 24 | $-31.2M | $11.1M | ||
| Q2 24 | $-30.6M | $-6.0M | ||
| Q1 24 | $-29.8M | $7.4M |
| Q4 25 | 33.5% | 23.0% | ||
| Q3 25 | -51765.6% | 3.8% | ||
| Q2 25 | -289620.0% | 0.4% | ||
| Q1 25 | -345635.7% | 0.2% | ||
| Q4 24 | -13837100.0% | 17.3% | ||
| Q3 24 | -1038966.7% | 8.9% | ||
| Q2 24 | -611840.0% | -5.0% | ||
| Q1 24 | -106421.4% | 6.6% |
| Q4 25 | 0.1% | 2.9% | ||
| Q3 25 | 101.1% | 3.4% | ||
| Q2 25 | 440.0% | 2.9% | ||
| Q1 25 | 4507.1% | 4.3% | ||
| Q4 24 | 378600.0% | 4.0% | ||
| Q3 24 | 59266.7% | 1.2% | ||
| Q2 24 | 6980.0% | 1.0% | ||
| Q1 24 | 2535.7% | 1.3% |
| Q4 25 | 1.47× | 5.39× | ||
| Q3 25 | — | 4.32× | ||
| Q2 25 | — | 8.39× | ||
| Q1 25 | — | 1.17× | ||
| Q4 24 | — | 3.94× | ||
| Q3 24 | — | 9.70× | ||
| Q2 24 | — | -0.79× | ||
| Q1 24 | — | 1.63× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FDMT
Segment breakdown not available.
PMTS
| US Debit And Credit | $128.9M | 84% |
| US Prepaid Debit | $24.4M | 16% |
